The time-to-surgery interval and its effect on pathological response after neoadjuvant chemoimmunotherapy in non-small cell lung cancer: a retrospective cohort study
TTS ≤4 weeks was associated with a significant improvement of pathological response. Therefore, patients with NSCLC should undergo surgery within 4 weeks after the last cycle of neoadjuvant chemoimmunotherapy.
Authors
- Chang-Yong Tong
- Antônio Rossi (ORCID: https://orcid.org/0000-0003-3295-0345)
- Hiroyuki Adachi (ORCID: https://orcid.org/0000-0002-8928-9394)
- Dabing Huang (ORCID: https://orcid.org/0000-0002-3040-3017)
- Miao Miao (ORCID: https://orcid.org/0000-0002-1915-577X)
- Shuai-Dong Lin
- Jing Guo (ORCID: https://orcid.org/0000-0003-1048-2886)
- Wenxin Zheng (ORCID: https://orcid.org/0000-0002-0682-273X)
Institutions
- Ningbo University (CN)
- Yokohama City University (JP)
Publication Details
- Journal
- Translational Lung Cancer Research
- Published
- 2024-10-01
- DOI
- https://doi.org/10.21037/tlcr-24-781
- Citations
- 2
- Primary Topic
- Lung Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.84